#mpnsm
LightNews LightNews
eshaematology.bsky.social
📣 #ESHCMLMPN2027: PROGRAMME HIGHLIGHT:
3 SIMULTANEOUS MEET THE EXPERT SESSIONS
5th How to Diagnose and Treat
CML/MPN
March 5-7, 2027 / Prague, Czech Republic
Chairs: Claire Harrison, Andreas Hochhaus, Ruben Mesa
More information ➡ bit.ly/3Z8y3tI
#ESHCONFERENCES #MPNsm #CMLsm
November 4, 2026 at 12:27 PM
eshaematology.bsky.social
📣 #ESHCMLMPN2027: PROGRAMME HIGHLIGHT:
DEBATE 2 "Do we need the term "Front line for targeted therapies in MPN"
5th How to Diagnose and Treat CML/MPN
March 5-7, 2027/Prague, Czech Republic
Chairs: Claire Harrison, Andreas Hochhaus, Ruben Mesa
More info ➡ bit.ly/3Z8y3tI
#ESHCONFERENCES #MPNsm #CMLsm
With @rubenmesamd.bsky.social
October 21, 2026 at 9:10 AM
eshaematology.bsky.social
10th Translational Research Conference on Myelodysplastic Syndromes, Overlap MDS/MPN Disorders and Clonal Haematopoiesis

Chair: Pierre Fenaux

#ESHCONFERENCES #HEMATOLOGY #HAEMATOLOGY #MDSsm #MPNsm #ESHYOUNGREPORTERS #ESHELEARNING
October 18, 2026 at 10:51 AM
eshaematology.bsky.social
10th Translational Research Conference on Myelodysplastic Syndromes, Overlap MDS/MPN Disorders and Clonal Haematopoiesis

#ESHCONFERENCES #HEMATOLOGY #HAEMATOLOGY #MDSsm #MPNsm #ESHYOUNGREPORTERS #ESHELEARNING
October 18, 2026 at 7:31 AM
eshaematology.bsky.social
10th Translational Research Conference on Myelodysplastic Syndromes, Overlap MDS/MPN Disorders and Clonal Haematopoiesis

Chair: Guillermo Garcia-Manero

#ESHCONFERENCES #HEMATOLOGY #HAEMATOLOGY #MDSsm #MPNsm #ESHYOUNGREPORTERS #ESHELEARNING
October 18, 2026 at 8:56 AM
eshaematology.bsky.social
#ESHMDS2026: and a special thanks to Marco Gabriele Raddi & Pierre Walczak, #ESHYOUNGREPORTERS, for lively reporting this conference from a scientific perspective!
Conference Chairs: Pierre Fenaux, Katharina Götze, @mikkaelsekeres.bsky.social
➡ bit.ly/4lpZ7yA
#ESHCONFERENCES #MDSsm #MPNsm
with @amydezern.bsky.social @kenfigueroa.bsky.social @nancygillis.bsky.social @emmamgroarke.bsky.social @kikosole.bsky.social
October 18, 2026 at 12:03 PM
eshaematology.bsky.social
Another round of great Meet the Expert sessions @ #ESHMDS2026!
Valeria Santini, @mikkaelsekeres.bsky.social & Raphaël Itzykson shared informal discussions with participants!
➡ bit.ly/4lpZ7yA
#ESHCONFERENCES #MDSsm #MPNsm #HEMATOLOGY #HAEMATOLOGY #ESHYOUNGREPORTERS #ESHELEARNING
With @amydezern.bsky.social @kenfigueroa.bsky.social @nancygillis.bsky.social @emmamgroarke.bsky.social @kikosole.bsky.social
October 18, 2026 at 7:04 AM
eshaematology.bsky.social
10th Translational Research Conference on Myelodysplastic Syndromes, Overlap MDS/MPN Disorders and Clonal Haematopoiesis

Chair: Amer Zeidan

#ESHCONFERENCES #HEMATOLOGY #HAEMATOLOGY #MDSsm #MPNsm #ESHYOUNGREPORTERS #ESHELEARNING
October 17, 2026 at 5:23 PM
eshaematology.bsky.social
10th Translational Research Conference on Myelodysplastic Syndromes, Overlap MDS/MPN Disorders and Clonal Haematopoiesis

Chair: @mikkaelsekeres.bsky.social

#ESHCONFERENCES #HEMATOLOGY #HAEMATOLOGY #MDSsm #MPNsm #ESHYOUNGREPORTERS #ESHELEARNING
October 17, 2026 at 2:46 PM
eshaematology.bsky.social
10th Translational Research Conference on Myelodysplastic Syndromes, Overlap MDS/MPN Disorders and Clonal Haematopoiesis

#ESHCONFERENCES #HEMATOLOGY #HAEMATOLOGY #MDSsm #MPNsm #ESHYOUNGREPORTERS #ESHELEARNING
October 17, 2026 at 10:26 AM
eshaematology.bsky.social
Informal and engaging discussions during #ESHMDS2026 Meet the Expert sessions with Fabio Efficace & Klaus Metzeler. A great way to start Day 2 !
Conference Chairs: Pierre Fenaux, Katharina Götze, @mikkaelsekeres.bsky.social
➡ bit.ly/4lpZ7yA
#ESHCONFERENCES #HAEMATOLOGY #MDSsm #MPNsm
With @amydezern.bsky.social @kenfigueroa.bsky.social @nancygillis.bsky.social @emmamgroarke.bsky.social @mikkaelsekeres.bsky.social @kikosole.bsky.social
October 17, 2026 at 8:45 AM
eshaematology.bsky.social
10th Translational Research Conference on Myelodysplastic Syndromes, Overlap MDS/MPN Disorders and Clonal Haematopoiesis

Chair: Valeria Santini

#ESHCONFERENCES #HEMATOLOGY #HAEMATOLOGY #MDSsm #MPNsm #ESHYOUNGREPORTERS #ESHELEARNING
October 17, 2026 at 10:51 AM
eshaematology.bsky.social
#MDS / #MPN Disorders & Clonal Haematopoiesis.Oct 16-19

#ESHMDS2026 #ESHCONFERENCES #MDSsm #MPNsm
#ESHELEARNING #HAEMATOLOGY #HEMATOLOGY #HEALTHCARE
October 16, 2026 at 6:40 PM
eshaematology.bsky.social
#MDS / #MPN Disorders & Clonal Haematopoiesis.Oct 16-19
Chairs: Pierre Fenaux, Katharina Götze,
@mikkaelsekeres.bsky.social

Speakers:
Olivier Kosmider
@emmamgroarke.bsky.social
Thibault Comont

#ESHMDS2026 #ESHCONFERENCES #MDSsm #MPNsm
#ESHELEARNING #HAEMATOLOGY #HEMATOLOGY #HEALTHCARE
October 16, 2026 at 11:49 AM
eshaematology.bsky.social
#MDS / #MPN Disorders & Clonal Haematopoiesis.Oct 16-19
Chair: Pierre Fenaux

Speakers:
Robert Hasserjian
Aristoteles Giagounidis
@nancygillis.bsky.social

#ESHMDS2026 #ESHCONFERENCES #MDSsm #MPNsm
#ESHELEARNING #HAEMATOLOGY #HEMATOLOGY #HEALTHCARE
October 16, 2026 at 3:44 PM
eshaematology.bsky.social
#MDS / #MPN Disorders & Clonal Haematopoiesis.Oct 16-19
Chair: Michaela Fontenay

Speakers:
Marie Sebert
@kikosole.bsky.social
Michaela Fontenay
Raphaël Itzykson

#ESHMDS2026 #ESHCONFERENCES #MDSsm #MPNsm
#ESHELEARNING #HAEMATOLOGY #HEMATOLOGY #HEALTHCARE
October 16, 2026 at 5:31 PM
eshaematology.bsky.social
#MDS / #MPN Disorders & Clonal Haematopoiesis.Oct 16-19
Chairs: Pierre Fenaux, Katharina Götze,
@mikkaelsekeres.bsky.social

Speakers:
Klaus Metzeler
@amydezern.bsky.social
@nancygillis.bsky.social

#ESHMDS2026 #ESHCONFERENCES #MDSsm #MPNsm
#ESHELEARNING #HAEMATOLOGY #HEMATOLOGY #HEALTHCARE
October 16, 2026 at 9:47 AM
eshaematology.bsky.social
A friendly get together to close #ESHMDS2026 conference’s 1st day. Mentored Poster Walks & informal scientific exchange between colleagues & friends.
Thank you to all Poster Presenters & to Klaus Metzeler & Katja Sockel for your mentorship!
See you tomorrow at 8:40am!
#ESHCONFERENCES #MDSsm #MPNsm
with @amydezern.bsky.social @kenfigueroa.bsky.social @nancygillis.bsky.social @emmamgroarke.bsky.social @mikkaelsekeres.bsky.social @kikosole.bsky.social
October 16, 2026 at 7:05 PM
eshaematology.bsky.social
Welcome to #ESHMDS2026!
Stay tuned! ESH Young Scientific Reporters Marco Gabriele Raddi & Pierre Walczak will provide regular updates on the conference!
Conference Chairs: Pierre Fenaux, Katharina Götze, @mikkaelsekeres.bsky.social
➡ bit.ly/4lpZ7yA
#ESHCONFERENCES #MDSsm #MPNsm #ESHYOUNGREPORTERS
with @amydezern.bsky.social, @kenfigueroa.bsky.social, @nancygillis.bsky.social, @emmamgroarke.bsky.social, @kikosole.bsky.social
October 16, 2026 at 7:55 AM
ash.hematology.org
New evidence-based recommendations on #myelofibrosis address routine clinical questions and identify where stronger evidence is needed to improve care.

Learn more about the guidelines: https://ow.ly/5Wz150ZXGos

#MPNsm #Hematology #HemeSky #MedSky
October 14, 2026 at 3:11 PM
onclive.bsky.social
Did you miss key updates in NSCLC, breast cancer, MDS, and PTLD? Test your knowledge with this week's OncLive news quiz #lcsm #bcsm #mpnsm #oncology

www.onclive.com/view/onclive...
OncLive Weekly News Quiz (10/2/2026): Did You Miss Crucial Lung Cancer, Breast Cancer, MDS, and PTLD Updates? | OncLive
Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.
www.onclive.com
October 2, 2026 at 2:01 PM
onclive.bsky.social
📰Topline data from the phase 3 portion of the AZTOUND trial showed oral azacitidine and cedazuridine met the pharmacokinetic primary end point in patients with MDS or CMML #mpnsm #leusm #oncology

Read more: www.onclive.com/view/oral-az...
Oral Azacitidine and Cedazuridine Meets Primary Pharmacokinetic End Point in MDS and CMML | OncLive
Oral azacitidine and cedazuridine met the end point of total cycle azacitidine exposure vs subcutaneous azacitidine in MDS or CMML.
www.onclive.com
October 1, 2026 at 2:54 PM
eshaematology.bsky.social
📣 #ESHCMLMPN2027: PROGRAMME HIGHLIGHT:
DEBATE 1 Do we need the term "accelerated phase" CML in the TKI era?
5th How to Diagnose and Treat CML/MPN
March 5-7, 2027/Prague, Czech Republic
Chairs: Claire Harrison, Andreas Hochhaus, Ruben Mesa
More info ➡ bit.ly/3Z8y3tI
#ESHCONFERENCES #MPNsm #CMLsm
September 30, 2026 at 8:53 AM
onclive.bsky.social
⚛️ "What I would emphasize is the need to maintain dose intensity, and that should color how and which JAK inhibitor people use, rather than using suboptimal doses of drugs," said @raajitrampal.bsky.social of @mskcancercenter.bsky.social

Read more here ➡️: www.onclive.com/view/dose-in...

#mpnsm
Dose Intensity Anchors JAK Inhibitor Selection as Combinations and Targeted Agents Expand Options in Myelofibrosis | OncLive
Raajit K. Rampal, MD, PhD, discusses JAK inhibitor choice in cytopenic myelofibrosis, emerging combinations, and anemia-directed agents.
www.onclive.com
September 28, 2026 at 9:06 PM
onclive.bsky.social
📈MPN expert, Andrew Kuykendall, MD, of Moffitt Cancer Center, ranked these headlining novel treatments in MPNs at #SOHO2026.

‼️Visit our site for more: www.onclive.com/conference/s...

@societyofhemonc.bsky.social #mpnsm #oncology #hematology #cancer
September 11, 2026 at 7:19 PM